Polyphenols, not fibre: Greenvit makes the case for aronia as a selective microbiome modulator
Polish botanical extract specialist Greenvit has introduced ARONVIT®, a concentrated aronia berry (Aronia melanocarpa) extract powder positioned as a polyphenol-driven prebiotic alternative to conventional fibre-based gut health ingredients. Greenvit launched ARONVIT at Vitafoods Europe in Barcelona.
The ingredient’s commercial pitch rests on a body of clinical evidence suggesting that aronia polyphenols, including anthocyanins, proanthocyanidins, and tannins, can modulate the gut microbiome through a mechanism distinct from fermentable fibre.
Polyphenols as prebiotics, not just antioxidants
The conventional prebiotic model relies on dietary fibre passing undigested through the upper gastrointestinal tract and undergoing bacterial fermentation in the colon. Greenvit’s position is that aronia polyphenols follow a parallel but gentler route. Because they are not fully absorbed in the upper GI, a significant fraction reaches the colon, where they selectively fuel beneficial bacterial populations. Rafał Pietruszyński, CEO of Greenvit, noted that the dose profile sets ARONVIT apart from traditional fibre supplements: “To get a measurable prebiotic effect from fibre, you often need a large amount, typically 5g to 10g or more per day. ARONVIT offers a gentle, low-dose solution for microbiome support, making it an ideal choice for consumers seeking better digestive health without the bulk of traditional fibres.”
Pietruszyński explained that unlike traditional fibre fermentation, polyphenol metabolism in the colon proceeds more slowly and gently, and is associated with less gas production. This makes it better suited to consumers with limited fibre tolerance, for whom conventional prebiotic doses can cause bloating or gastrointestinal discomfort.
Short-chain fatty acids and selective bacterial growth
According to Greenvit’s review of published clinical data, aronia polyphenols act as selective fuel for beneficial bacteria, supporting the production of short-chain fatty acids (SCFAs), particularly butyrate. These SCFAs in turn promote the growth of Akkermansia muciniphila and Bifidobacterium species, contributing to improved microbial balance. ARONVIT is sourced from the Nero-Eggert variety of aronia, selected for its high polyphenol yield, and processed without solvents.
A GLP-1 connection via enzymatic inhibition
Beyond microbiome modulation, Greenvit highlights a second mechanistic pathway relating to metabolic health. A healthy SCFA-producing microbiome stimulates L-cells in the gut lining to secrete glucagon-like peptide-1 (GLP-1), the incretin hormone involved in appetite regulation and blood glucose control. Separately, a specific aronia bioactive, cyanidin 3,5-diglucoside, has been identified in studies as an inhibitor of the DPP-IV enzyme, which ordinarily degrades GLP-1 rapidly after secretion. By slowing this breakdown, the compound extends GLP-1 activity.
Pietruszyński noted that this as a complementary rather than pharmaceutical action: “These findings support the holistic approach of Aronvit for metabolic wellness.”
Formulator appeal
From a product development standpoint, the low-dose format has practical implications. As Pietruszyński noted: “Supplement brands prefer low-dose ingredients because they fit easily into smaller capsules or shots without adding bulk.”
Greenvit describes ARONVIT as “the gentle prebiotic modulator”, intended to work alongside conventional biotics in formulations targeting digestive comfort, intestinal barrier integrity, and metabolic balance.
For more information, visit: www.aronvit.com
Digital issue: Please click here for more information
